Query         psy1522
Match_columns 339
No_of_seqs    201 out of 253
Neff          3.5 
Searched_HMMs 46136
Date          Sat Aug 17 00:17:00 2013
Command       hhsearch -i /work/01045/syshi/Psyhhblits/psy1522.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/1522hhsearch_cdd -cpu 12 -v 0 

 No Hit                             Prob E-value P-value  Score    SS Cols Query HMM  Template HMM
  1 KOG4006|consensus              100.0 7.8E-47 1.7E-51  359.9  13.2  244    2-317     1-280 (311)
  2 smart00099 btg1 tob/btg1 famil 100.0 7.3E-46 1.6E-50  309.9  11.6  102    2-127     1-104 (108)
  3 PF07742 BTG:  BTG family;  Int 100.0 6.2E-44 1.3E-48  301.1   7.2  102    2-127     1-106 (118)
  4 KOG4006|consensus               99.7 4.3E-18 9.4E-23  163.5   0.5  101    1-127    65-169 (311)
  5 PF07742 BTG:  BTG family;  Int  99.4 5.3E-14 1.2E-18  119.4   3.4   53  117-173    60-115 (118)
  6 smart00099 btg1 tob/btg1 famil  99.4   3E-13 6.4E-18  114.0   5.0   47  116-168    59-108 (108)
  7 PF02159 Oest_recep:  Oestrogen  74.4     3.2   7E-05   37.2   3.2   40  283-326    69-108 (139)
  8 KOG0260|consensus               68.0      40 0.00087   39.7  10.4   13  304-316  1568-1580(1605)
  9 PF07145 PAM2:  Ataxin-2 C-term  62.6     4.3 9.4E-05   25.0   1.1   12  288-299     5-16  (18)
 10 KOG0260|consensus               57.6      56  0.0012   38.6   9.2   17  189-205  1472-1488(1605)
 11 cd00153 RalGDS_RA Ubiquitin do  45.1      13 0.00028   31.1   1.5   37   77-113    15-58  (87)
 12 PF05534 HicB:  HicB family;  I  41.4      28  0.0006   25.8   2.6   37   70-108    11-47  (51)
 13 PF04405 ScdA_N:  Domain of Unk  33.1      33 0.00072   26.0   2.0   21   91-111    32-52  (56)
 14 PF08671 SinI:  Anti-repressor   30.1      40 0.00087   23.0   1.8   20   92-111     7-26  (30)
 15 PF14437 MafB19-deam:  MafB19-l  29.9      78  0.0017   28.7   4.1   34  112-147    99-132 (146)
 16 COG2442 Uncharacterized conser  29.7      96  0.0021   25.2   4.2   43   69-112    12-54  (79)
 17 PF14437 MafB19-deam:  MafB19-l  28.8      23  0.0005   32.0   0.6   27  138-165    83-111 (146)
 18 PF15508 NAAA-beta:  beta subun  28.3 3.1E+02  0.0067   22.2   7.0   39    3-41     26-64  (95)
 19 PF06228 ChuX_HutX:  Haem utili  27.9      67  0.0014   28.6   3.3   26   96-121     1-26  (141)
 20 cd03026 AhpF_NTD_C TRX-GRX-lik  22.3      64  0.0014   25.7   2.0   34  112-145    13-47  (89)
 21 cd01768 RA RA (Ras-associating  21.9   1E+02  0.0022   23.8   2.9   42   70-118     5-48  (87)
 22 PF00788 RA:  Ras association (  21.8      58  0.0013   24.8   1.6   49   73-127    11-62  (93)
 23 COG0560 SerB Phosphoserine pho  21.6 3.5E+02  0.0075   25.0   6.8   71   76-146    90-162 (212)
 24 KOG3784|consensus               21.4 3.8E+02  0.0083   28.2   7.7   95   20-125    63-165 (407)
 25 COG3112 Uncharacterized protei  21.1      80  0.0017   27.9   2.4   38   88-127    38-75  (121)
 26 PF14941 OAF:  Transcriptional   20.1      43 0.00094   32.6   0.6   18   68-85    194-219 (240)

No 1  
>KOG4006|consensus
Probab=100.00  E-value=7.8e-47  Score=359.95  Aligned_cols=244  Identities=42%  Similarity=0.660  Sum_probs=191.0

Q ss_pred             cHHHHHHHHHHHHHHHhccCChhHHHHHHHHHHHHHHHHhcCCCCCCCCCCCccchhHHHhhhccCCCCCCCCCCCccee
Q psy1522           2 MHVEIQVALNFVISYLYNKLPRRRVNIFGEELEKALKEKFSGHWYPGKPLKDSSTNNKALKEKFSGHWYPGKPLKGSAFR   81 (339)
Q Consensus         2 M~~EI~aAVnFl~~~L~~klprrrv~~F~e~L~~~L~erf~~~w~~~~~~~~~~~le~~L~e~f~~HWyP~~P~kGsayR   81 (339)
                      |++||++||||||+|||+|||||||+||+|||+++|++||++                        ||||++|.|||+||
T Consensus         1 m~~ei~valnfvisylynklprrrv~ifgeele~~l~~k~~~------------------------hwypekp~kgs~~r   56 (311)
T KOG4006|consen    1 MQLEIQVALNFVISYLYNKLPRRRVNIFGEELERLLKKKFEG------------------------HWYPEKPKKGSGFR   56 (311)
T ss_pred             CcchHHHHHHHHHHHHhccCCccccchhHHHHHHHHHHhhcC------------------------ccCCCCCCCccccc
Confidence            999999999999999999999999999999999999999999                        99999999999999


Q ss_pred             EEecCCCCCHHHHHHHHHhCCCHHHHHhcCCCccEEEEcCCCCCCCCCCHHHHHHHHHcC-CCHHHhhhcCCCCceeeec
Q psy1522          82 CLKTGDPIDPVLEIAARESGVAIQDVLENLPSELAVWVDPGEVTGDPIDPVLEIAARESG-VAIQDVLENLPSELAVWVD  160 (339)
Q Consensus        82 CIri~~~~Dpvl~~AA~esGl~~~dL~~~LP~EltlWVDPgeVSyR~~Dpvl~kAa~ESG-L~~~dl~l~LP~ELTlWVD  160 (339)
                      ||+  +.+|++++.||+|+|+.++||+++||.++.+||||++|++|       .  +|.| ++.            +|+|
T Consensus        57 cih--~~~d~vme~eiaeag~fisdvlrnlp~~lsv~idpFevslq-------i--~ekg~yK~------------hw~~  113 (311)
T KOG4006|consen   57 CIH--ETVDPVMESEIAEAGVFISDVLRNLPKLLSVWIDPFEVSLQ-------I--GEKGAYKV------------HWFP  113 (311)
T ss_pred             hhc--ccccHHHHHHHHHhcCCHHHHHHhCcchhheeecchhhHHh-------h--hhccceee------------eecC
Confidence            999  88999999999999999999999999999999999999999       5  5555 222            2443


Q ss_pred             CcccccCCCCcccCCCccccccccccccccCCCCcccccccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCcccchh
Q psy1522         161 PGEVRGEREIATADPSLHAAAMDREVHKTFNPEARVFRPVEVCLASLSLNGEERSASPSPTKGSPTFLPRSTAPLTFTTA  240 (339)
Q Consensus       161 P~EVsGE~~~~~~~a~~~~~~~d~E~sk~i~pea~~F~P~~~~~~~~s~~p~~~~as~s~~spsP~f~~~~~~p~tf~~~  240 (339)
                      =-+-+|                +.+..++|+   +.|||++|||+++..     ..++.+..++|+++.+..+|++|++.
T Consensus       114 d~p~kG----------------~~~rcirIn---~~~npdaq~~~~i~~-----~~ss~s~~~lPtelt~wvdP~evs~r  169 (311)
T KOG4006|consen  114 DKPSKG----------------QAYRCIRIN---KSFNPDAQVFRPIGA-----SNSSVSNLGLPTELTLWVDPIEVSTR  169 (311)
T ss_pred             CCCCCC----------------chhhhHHHh---hccCCchhhhhcccc-----cccchhccCCCcccccccCceEEEee
Confidence            222111                114445554   667777777776655     33344456688999888888888755


Q ss_pred             h-------------------------h----hhccccccccccCccccC-----CCCCCchhHHHHHHHHHhhhccCCC-
Q psy1522         241 S-------------------------F----AQTKFGSTKLKTNSKRTN-----RMSPTEFSNYIKQRALLQQQHNNHP-  285 (339)
Q Consensus       241 t-------------------------F----a~tkFgsTK~~s~~kr~~-----~~spt~~~~~~k~~~~~~~~h~~~~-  285 (339)
                      +                         |    +.| |+++|..+-++|..     +|+|+++++++++.+++|++|..++ 
T Consensus       170 ~~~~~gek~~~~~~a~s~~g~~~p~~~~~k~~~a-~~s~s~~~~sg~s~s~~~~~~~~~s~p~t~~~sp~~q~~~~~~~~  248 (311)
T KOG4006|consen  170 SFPIGGEKNNAALVASSPLGAEYPDEFVRKATSA-LDSCSSQTLSGRSSSSESYSKSPASPPPTMPVSPYQQQQQLSSAS  248 (311)
T ss_pred             ecccCccccchhheecccccccCchHHHHHHHhh-ccchhhhhhcCccCchhhcccCcCCCCCCCCcChHHHHHhhcCCC
Confidence            2                         2    222 56666665556655     6889999999999999998887765 


Q ss_pred             CCCCCCCccccccCCCCCCCCCCCCCCCCCcc
Q psy1522         286 QPSLPPTLSNFLHSPGAQSPHYSPNTPSGNTA  317 (339)
Q Consensus       286 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (339)
                      .|+.-+....=++.-|.-+|+|.|+.|-|+..
T Consensus       249 sPs~~~~~~~~~~gq~s~~~~~~p~~~~~ys~  280 (311)
T KOG4006|consen  249 SPSATYSPRKKMYGQVSYTPGFFPGVPFGYSN  280 (311)
T ss_pred             CCcccccchhhhccccCCCCCCCCCCCcCccc
Confidence            45433333333777888999999999877653


No 2  
>smart00099 btg1 tob/btg1 family. The tob/btg1 is a family of proteins that inhibit cell proliferation.
Probab=100.00  E-value=7.3e-46  Score=309.92  Aligned_cols=102  Identities=54%  Similarity=0.964  Sum_probs=101.1

Q ss_pred             cHHHHHHHHHHHHHHH--hccCChhHHHHHHHHHHHHHHHHhcCCCCCCCCCCCccchhHHHhhhccCCCCCCCCCCCcc
Q psy1522           2 MHVEIQVALNFVISYL--YNKLPRRRVNIFGEELEKALKEKFSGHWYPGKPLKDSSTNNKALKEKFSGHWYPGKPLKGSA   79 (339)
Q Consensus         2 M~~EI~aAVnFl~~~L--~~klprrrv~~F~e~L~~~L~erf~~~w~~~~~~~~~~~le~~L~e~f~~HWyP~~P~kGsa   79 (339)
                      |++||++|||||++||  ++|||++++++|+++|+++|.+||++                        ||||++|.||||
T Consensus         1 M~~EI~~av~Fl~~~l~~~~~l~~~~v~~F~~~L~~~L~~~y~~------------------------HWyP~~P~kGqa   56 (108)
T smart00099        1 MKLEIAAAVNFITSLLRKHNKLSKRRVEIFAEKLTRLLKEKYKN------------------------HWYPEKPYKGSG   56 (108)
T ss_pred             ChHHHHHHHHHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc------------------------CCCCCCCCCCcc
Confidence            9999999999999999  89999999999999999999999999                        999999999999


Q ss_pred             eeEEecCCCCCHHHHHHHHHhCCCHHHHHhcCCCccEEEEcCCCCCCC
Q psy1522          80 FRCLKTGDPIDPVLEIAARESGVAIQDVLENLPSELAVWVDPGEVTGD  127 (339)
Q Consensus        80 yRCIri~~~~Dpvl~~AA~esGl~~~dL~~~LP~EltlWVDPgeVSyR  127 (339)
                      ||||+||+++||+|++||+++||+++||.++||+||||||||||||||
T Consensus        57 yRCIrIn~~~Dp~l~~Aa~~sGl~~~~l~~~LP~eltiwvDP~eVs~R  104 (108)
T smart00099       57 FRCIRINQKVDPVIEQACKESGLDIDDLGGNLPKELTLWVDPFEVSYR  104 (108)
T ss_pred             eEEEEECCcCCHHHHHHHHHhCCCHHHHHHhCCcccEEEECCCEEEEe
Confidence            999999999999999999999999999999999999999999999999


No 3  
>PF07742 BTG:  BTG family;  InterPro: IPR002087 Anti-proliferative proteins have been shown to include mammalian and avian protein BTG1 (which appears to be involved in negative regulation of cell proliferation) and rat/mouse NGF-inducible protein PC3/TIS21 (BTG2) [, , ]. These proteins have from 158 to 363 amino acid residues, that are highly similar and include 3 conserved cysteine residues. BTG2 seems to have a signal sequence; while the other proteins may lack such a domain. The sequence of the N-terminal half of these proteins is well conserved.; PDB: 3DJU_B 3E9V_A 2Z15_D 2D5R_B 3DJN_B.
Probab=100.00  E-value=6.2e-44  Score=301.09  Aligned_cols=102  Identities=55%  Similarity=1.003  Sum_probs=92.7

Q ss_pred             cHHHHHHHHHHHHHHHhcc--CChhHHHHHHHHHHHHHHHHhcCCCCCCCCCCCccchhHHHhhhccCCCCCCCCCCCcc
Q psy1522           2 MHVEIQVALNFVISYLYNK--LPRRRVNIFGEELEKALKEKFSGHWYPGKPLKDSSTNNKALKEKFSGHWYPGKPLKGSA   79 (339)
Q Consensus         2 M~~EI~aAVnFl~~~L~~k--lprrrv~~F~e~L~~~L~erf~~~w~~~~~~~~~~~le~~L~e~f~~HWyP~~P~kGsa   79 (339)
                      |++||++|||||++||+++  ||++++++|+++|+++|.+||++                        ||||++|.||||
T Consensus         1 M~~EI~~av~Fl~~~l~~~~~l~~~~~~~F~~~L~~~L~~ry~~------------------------HW~P~~P~kGsa   56 (118)
T PF07742_consen    1 MKTEIAAAVNFLTRLLYNKGRLPRRQVDRFAEELENLLCERYKG------------------------HWYPENPSKGSA   56 (118)
T ss_dssp             CHHHHHHHHHHHHHHHHHHC-B-HHHHHHHHHHHHHHHHHHHTT------------------------S--TTSTTTTHH
T ss_pred             CHHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC------------------------CCCCCCCCCCCc
Confidence            9999999999999999987  99999999999999999999999                        999999999999


Q ss_pred             eeEEecC--CCCCHHHHHHHHHhCCCHHHHHhcCCCccEEEEcCCCCCCC
Q psy1522          80 FRCLKTG--DPIDPVLEIAARESGVAIQDVLENLPSELAVWVDPGEVTGD  127 (339)
Q Consensus        80 yRCIri~--~~~Dpvl~~AA~esGl~~~dL~~~LP~EltlWVDPgeVSyR  127 (339)
                      ||||+||  +++||+|++||.++||+++||.++||.||||||||||||||
T Consensus        57 yRcIrin~~~~~Dp~l~~Aa~~sgl~~~~l~~~LP~eltlWvDPgeVs~R  106 (118)
T PF07742_consen   57 YRCIRINPGHKMDPVLEQAAKESGLSYEDLRSLLPRELTLWVDPGEVSYR  106 (118)
T ss_dssp             HH-EEES--SSB-HHHHHHHHHTT--HHHHHHHS-TTEEEEEETTEEEEE
T ss_pred             eEEEEEcCCCCCCHHHHHHHHHhCCCHHHHHHhcchhcEEEECCCEEEEE
Confidence            9999998  99999999999999999999999999999999999999999


No 4  
>KOG4006|consensus
Probab=99.68  E-value=4.3e-18  Score=163.55  Aligned_cols=101  Identities=33%  Similarity=0.586  Sum_probs=87.0

Q ss_pred             CcHHHHHHHHHHHHHHHhc--cCChhHHHHHHHHHHHHHHHHhcCCCCCCCCCCCccchhHHHhhhccCCCCCCCCCCCc
Q psy1522           1 MMHVEIQVALNFVISYLYN--KLPRRRVNIFGEELEKALKEKFSGHWYPGKPLKDSSTNNKALKEKFSGHWYPGKPLKGS   78 (339)
Q Consensus         1 ~M~~EI~aAVnFl~~~L~~--klprrrv~~F~e~L~~~L~erf~~~w~~~~~~~~~~~le~~L~e~f~~HWyP~~P~kGs   78 (339)
                      +|..||++||-||.++|++  ++-..+|+.|...|...|.++|+.                        ||+||+|+||+
T Consensus        65 vme~eiaeag~fisdvlrnlp~~lsv~idpFevslqi~ekg~yK~------------------------hw~~d~p~kG~  120 (311)
T KOG4006|consen   65 VMESEIAEAGVFISDVLRNLPKLLSVWIDPFEVSLQIGEKGAYKV------------------------HWFPDKPSKGQ  120 (311)
T ss_pred             HHHHHHHHhcCCHHHHHHhCcchhheeecchhhHHhhhhccceee------------------------eecCCCCCCCc
Confidence            4899999999999999975  688899999999999999988888                        99999999999


Q ss_pred             ceeEEecCCCCC--HHHHHHHHHhCCCHHHHHhcCCCccEEEEcCCCCCCC
Q psy1522          79 AFRCLKTGDPID--PVLEIAARESGVAIQDVLENLPSELAVWVDPGEVTGD  127 (339)
Q Consensus        79 ayRCIri~~~~D--pvl~~AA~esGl~~~dL~~~LP~EltlWVDPgeVSyR  127 (339)
                      +||||+|+..+|  +.+.+++.+++.+...+  .||.|+|+||||.+||||
T Consensus       121 ~~rcirIn~~~npdaq~~~~i~~~~ss~s~~--~lPtelt~wvdP~evs~r  169 (311)
T KOG4006|consen  121 AYRCIRINKSFNPDAQVFRPIGASNSSVSNL--GLPTELTLWVDPIEVSTR  169 (311)
T ss_pred             hhhhHHHhhccCCchhhhhcccccccchhcc--CCCcccccccCceEEEee
Confidence            999999987666  45555666666665555  689999999999999998


No 5  
>PF07742 BTG:  BTG family;  InterPro: IPR002087 Anti-proliferative proteins have been shown to include mammalian and avian protein BTG1 (which appears to be involved in negative regulation of cell proliferation) and rat/mouse NGF-inducible protein PC3/TIS21 (BTG2) [, , ]. These proteins have from 158 to 363 amino acid residues, that are highly similar and include 3 conserved cysteine residues. BTG2 seems to have a signal sequence; while the other proteins may lack such a domain. The sequence of the N-terminal half of these proteins is well conserved.; PDB: 3DJU_B 3E9V_A 2Z15_D 2D5R_B 3DJN_B.
Probab=99.44  E-value=5.3e-14  Score=119.39  Aligned_cols=53  Identities=49%  Similarity=0.904  Sum_probs=42.1

Q ss_pred             EEEcCCCCCCCCCCHHHHHHHHHcCCCHHHhhhcCCCCceeeecCcccc---cCCCCccc
Q psy1522         117 VWVDPGEVTGDPIDPVLEIAARESGVAIQDVLENLPSELAVWVDPGEVR---GEREIATA  173 (339)
Q Consensus       117 lWVDPgeVSyR~~Dpvl~kAa~ESGL~~~dl~l~LP~ELTlWVDP~EVs---GE~~~~~~  173 (339)
                      |-|++    ..++||+|++||.++|++++++...||+|||+||||+|||   ||+|.++|
T Consensus        60 Irin~----~~~~Dp~l~~Aa~~sgl~~~~l~~~LP~eltlWvDPgeVs~R~ge~g~~~v  115 (118)
T PF07742_consen   60 IRINP----GHKMDPVLEQAAKESGLSYEDLRSLLPRELTLWVDPGEVSYRIGEKGSICV  115 (118)
T ss_dssp             EEES------SSB-HHHHHHHHHTT--HHHHHHHS-TTEEEEEETTEEEEEESTTS-EEE
T ss_pred             EEEcC----CCCCCHHHHHHHHHhCCCHHHHHHhcchhcEEEECCCEEEEEEcCCCceEE
Confidence            46777    6789999999999999999999999999999999999999   99995544


No 6  
>smart00099 btg1 tob/btg1 family. The tob/btg1 is a family of proteins that inhibit cell proliferation.
Probab=99.39  E-value=3e-13  Score=113.99  Aligned_cols=47  Identities=49%  Similarity=0.897  Sum_probs=43.4

Q ss_pred             EEEEcCCCCCCCCCCHHHHHHHHHcCCCHHHhhhcCCCCceeeecCcccc---cCC
Q psy1522         116 AVWVDPGEVTGDPIDPVLEIAARESGVAIQDVLENLPSELAVWVDPGEVR---GER  168 (339)
Q Consensus       116 tlWVDPgeVSyR~~Dpvl~kAa~ESGL~~~dl~l~LP~ELTlWVDP~EVs---GE~  168 (339)
                      .|-|+      +++||+|++||.+|||++.+|...||+|||+||||+|||   ||+
T Consensus        59 CIrIn------~~~Dp~l~~Aa~~sGl~~~~l~~~LP~eltiwvDP~eVs~R~ge~  108 (108)
T smart00099       59 CIRIN------QKVDPVIEQACKESGLDIDDLGGNLPKELTLWVDPFEVSYRIGEK  108 (108)
T ss_pred             EEEEC------CcCCHHHHHHHHHhCCCHHHHHHhCCcccEEEECCCEEEEeecCC
Confidence            36676      799999999999999999999999999999999999999   774


No 7  
>PF02159 Oest_recep:  Oestrogen receptor;  InterPro: IPR001292 Steroid or nuclear hormone receptors (4A nuclear receptor, NRs) constitute an important superfamily of transcription regulators that are involved in widely diverse physiological functions, including control of embryonic development, cell differentiation and homeostasis. Members of the superfamily include the steroid hormone receptors and receptors for thyroid hormone, retinoids, 1,25-dihydroxy-vitamin D3 and a variety of other ligands []. The proteins function as dimeric molecules in nuclei to regulate the transcription of target genes in a ligand-responsive manner [, ]. In addition to C-terminal ligand-binding domains, these nuclear receptors contain a highly-conserved, N-terminal zinc-finger that mediates specific binding to target DNA sequences, termed ligand-responsive elements. In the absence of ligand, steroid hormone receptors are thought to be weakly associated with nuclear components; hormone binding greatly increases receptor affinity. NRs are extremely important in medical research, a large number of them being implicated in diseases such as cancer, diabetes, hormone resistance syndromes, etc. While several NRs act as ligand-inducible transcription factors, many do not yet have a defined ligand and are accordingly termed 'orphan' receptors. During the last decade, more than 300 NRs have been described, many of which are orphans, which cannot easily be named due to current nomenclature confusions in the literature. However, a new system has recently been introduced in an attempt to rationalise the increasingly complex set of names used to describe superfamily members. The oestrogen receptors (ERs) are steroid or nuclear hormone receptors that act as transcription regulators involved in diverse physiological functions. Oestrogen receptors function as dimeric molecules in nuclei to regulate the transcription of target genes in a ligand-responsive manner. The ER consists of three functional and structural domains: an N-terminal modulatory domain, a highly conserved DNA-binding domain that recognises specific sequences (IPR001628 from INTERPRO), and a C-terminal ligand-binding domain (IPR000536 from INTERPRO).  The N-terminal modulatory domain spans the first 180 residues and contains the activation function 1 (AF1) region. Nuclear receptors differ considerably with respect to AF1 activity and regulation, as it is a poorly conserved region []. There is another activation function region, namely AF2, which resides in the C-terminal end of the ligand-binding domain. Transcription activation is facilitated by both AF1 and AF2, which appear to act synergistically in the ER complex [, ]. For example, the ER can recruit TIF2 (transcription intermediary factor 2) via the AF1 and AF2 regions, whose synergistic action results in the activation of transcription.; GO: 0003677 DNA binding, 0005496 steroid binding, 0030284 estrogen receptor activity, 0006355 regulation of transcription, DNA-dependent, 0043401 steroid hormone mediated signaling pathway, 0005634 nucleus
Probab=74.40  E-value=3.2  Score=37.23  Aligned_cols=40  Identities=38%  Similarity=0.700  Sum_probs=33.7

Q ss_pred             CCCCCCCCCCccccccCCCCCCCCCCCCCCCCCccccCCccchh
Q psy1522         283 NHPQPSLPPTLSNFLHSPGAQSPHYSPNTPSGNTARSLSPSYYF  326 (339)
Q Consensus       283 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (339)
                      +++.|||||    |+|.+|-|-|||--|.+++-..|.-+|.-+|
T Consensus        69 ~~ssPQLSP----flH~~~qQvpyYLe~e~~~~~~rea~~t~~Y  108 (139)
T PF02159_consen   69 LPSSPQLSP----FLHPPGQQVPYYLENEQGSYGVREASPTPFY  108 (139)
T ss_pred             ecCCCccCc----cccCccccCceecccCCCcccccccCCCccc
Confidence            456667777    8999999999999999999999988776555


No 8  
>KOG0260|consensus
Probab=68.02  E-value=40  Score=39.70  Aligned_cols=13  Identities=62%  Similarity=0.984  Sum_probs=5.9

Q ss_pred             CCCCCCCCCCCCc
Q psy1522         304 SPHYSPNTPSGNT  316 (339)
Q Consensus       304 ~~~~~~~~~~~~~  316 (339)
                      ||.|||..||=.|
T Consensus      1568 spsysptspsys~ 1580 (1605)
T KOG0260|consen 1568 SPSYSPTSPSYST 1580 (1605)
T ss_pred             CCCCCCCCCCccC
Confidence            4444444444433


No 9  
>PF07145 PAM2:  Ataxin-2 C-terminal region;  InterPro: IPR009818 This entry represents a conserved region approximately 250 residues long located towards the C terminus of eukaryotic ataxin-2. Ataxin-2 is a protein of unknown function, within which expansion of a polyglutamine tract (due to expansion of unstable CAG repeats in the coding region of the SCA2 gene) causes spinocerebellar ataxia type 2 (SCA2), a late-onset neurodegenerative disorder []. The expanded polyglutamine repeat in ataxin-2 causes disruption of the normal morphology of the Golgi complex and increased incidence of cell death []. Ataxin-2 is predicted to consist of mostly non-globular domains [].; PDB: 3NTW_B 1JH4_B 3KTR_B 3KUJ_B 3KUT_D 3KUS_D 1JGN_B 2RQG_A 2RQH_A.
Probab=62.63  E-value=4.3  Score=25.01  Aligned_cols=12  Identities=33%  Similarity=0.592  Sum_probs=9.7

Q ss_pred             CCCCCccccccC
Q psy1522         288 SLPPTLSNFLHS  299 (339)
Q Consensus       288 ~~~p~~~~~~~~  299 (339)
                      +|.|+|+|||.+
T Consensus         5 ~LNp~A~eFvP~   16 (18)
T PF07145_consen    5 KLNPNAPEFVPS   16 (18)
T ss_dssp             SSSTTSSSS-TT
T ss_pred             ccCCCCccccCC
Confidence            799999999964


No 10 
>KOG0260|consensus
Probab=57.57  E-value=56  Score=38.59  Aligned_cols=17  Identities=12%  Similarity=0.516  Sum_probs=7.8

Q ss_pred             ccCCCCccccccccccc
Q psy1522         189 TFNPEARVFRPVEVCLA  205 (339)
Q Consensus       189 ~i~pea~~F~P~~~~~~  205 (339)
                      +.+|-..++.|-.-..+
T Consensus      1472 ~~sptspsysptspsys 1488 (1605)
T KOG0260|consen 1472 SYSPTSPSYSPTSPSYS 1488 (1605)
T ss_pred             CCCCCCCCCCCCCCCCC
Confidence            34444455555444433


No 11 
>cd00153 RalGDS_RA Ubiquitin domain of  RalGDS-like factor (RLF) and related proteins. This CD represents the C-terminal Ras-associating (RA) domain of three closely related guanine-nucleotide exchange factors (GEF's),  Ral guanine nucleotide dissociation stimulator (RalGDS), RalGDS-like (RGL), and RalGDS-like factor (RLF).  The RalGDS proteins are downstream effectors of the Ras-related protein Ral, providing a mechanism for Ral activation by extracellular signals.  The RA domain is structurally similar to ubiquitin and exists in a number of other signalling proteins including AF6, rasfadin, SNX27, CYR1, and STE50.
Probab=45.11  E-value=13  Score=31.14  Aligned_cols=37  Identities=16%  Similarity=0.381  Sum_probs=30.2

Q ss_pred             CcceeEEec--CCCCCHHHHHHHHHhCCCHH-----HHHhcCCC
Q psy1522          77 GSAFRCLKT--GDPIDPVLEIAARESGVAIQ-----DVLENLPS  113 (339)
Q Consensus        77 GsayRCIri--~~~~Dpvl~~AA~esGl~~~-----dL~~~LP~  113 (339)
                      |.-|+||.+  ++++.-+|.+|-..-|++-+     +|.+.||.
T Consensus        15 gn~YKSIlltsqDktP~VI~ral~Khnl~~~~~~~Y~L~Q~Lp~   58 (87)
T cd00153          15 GNLYKSILLTSQDKAPQVIRRAMEKHNLESEVAEDYELVQVLPG   58 (87)
T ss_pred             cceEEEEEEecCCcCHHHHHHHHHHhCCCcCCccceEEEEEcCC
Confidence            999999987  58999999999999999754     35566773


No 12 
>PF05534 HicB:  HicB family;  InterPro: IPR008651 This family consists of several bacterial HicB related proteins. The function of HicB is unknown although it is thought to be involved in pilus formation. It has been speculated that HicB performs a function antagonistic to that of pili and yet is necessary for invasion of certain niches [].
Probab=41.44  E-value=28  Score=25.84  Aligned_cols=37  Identities=27%  Similarity=0.396  Sum_probs=29.4

Q ss_pred             CCCCCCCCcceeEEecCCCCCHHHHHHHHHhCCCHHHHH
Q psy1522          70 YPGKPLKGSAFRCLKTGDPIDPVLEIAARESGVAIQDVL  108 (339)
Q Consensus        70 yP~~P~kGsayRCIri~~~~Dpvl~~AA~esGl~~~dL~  108 (339)
                      -|++|.+|+  --||+...+..-+..+|.+.|++.+++.
T Consensus        11 ~p~k~~sg~--~~lRi~~~Lh~~l~~~A~~~gvSlN~~I   47 (51)
T PF05534_consen   11 EPEKPYSGK--FNLRIPPELHRALAEAAAAEGVSLNQWI   47 (51)
T ss_pred             CCCCCCCCc--eeeeCCHHHHHHHHHHHHHhCCCHHHHH
Confidence            477888864  4577777777888889999999999885


No 13 
>PF04405 ScdA_N:  Domain of Unknown function (DUF542)  ;  InterPro: IPR007500 This is a domain of unknown function found at the N terminus of genes involved in cell wall development and nitrous oxide protection. ScdA is required for normal cell growth and development; mutants have an increased level of peptidoglycan cross-linking and aberrant cellular morphology suggesting a role for ScdA in cell wall metabolism []. NorA1, NorA2, and YtfE are involved in the nitrous oxide response. NorA1 and NorA2, which are similar to YtfE, are co-transcribed with the membrane-bound nitrous oxide (NO) reductases. The genes appear to be involved in NO protection but their function is unknown [, ]. 
Probab=33.07  E-value=33  Score=26.01  Aligned_cols=21  Identities=43%  Similarity=0.569  Sum_probs=18.1

Q ss_pred             HHHHHHHHHhCCCHHHHHhcC
Q psy1522          91 PVLEIAARESGVAIQDVLENL  111 (339)
Q Consensus        91 pvl~~AA~esGl~~~dL~~~L  111 (339)
                      ..|..||++.||+.++|++-|
T Consensus        32 ~~L~eA~~~~~ld~~~vl~~L   52 (56)
T PF04405_consen   32 RSLEEACEEKGLDPEEVLEEL   52 (56)
T ss_pred             chHHHHHHHcCCCHHHHHHHH
Confidence            569999999999999987655


No 14 
>PF08671 SinI:  Anti-repressor SinI;  InterPro: IPR010981 The SinR repressor is part of a group of Sin (sporulation inhibition) proteins in Bacillus subtilis that regulate the commitment to sporulation in response to extreme adversity []. SinR is a tetrameric repressor protein that binds to the promoters of genes essential for entry into sporulation and prevents their transcription. This repression is overcome through the activity of SinI, which disrupts the SinR tetramer through the formation of a SinI-SinR heterodimer, thereby allowing sporulation to proceed. The SinR structure consists of two domains: a dimerisation domain stabilised by a hydrophobic core, and a DNA-binding domain that is identical to domains of the bacteriophage 434 CI and Cro proteins that regulate prophage induction. The dimerisation domain is a four-helical bundle formed from two helices from the C-terminal residues of SinR and two helices from the central residues of SinI. These regions in SinR and SinI are similar in both structure and sequence. The interaction of SinR monomers to form tetramers is weaker than between SinR and SinI, since SinI can effectively disrupt SinR tetramers. This entry represents the dimerisation domain in both SinI and SinR proteins.; GO: 0005488 binding, 0006355 regulation of transcription, DNA-dependent; PDB: 1B0N_A 2YAL_A.
Probab=30.08  E-value=40  Score=23.04  Aligned_cols=20  Identities=35%  Similarity=0.424  Sum_probs=13.9

Q ss_pred             HHHHHHHHhCCCHHHHHhcC
Q psy1522          92 VLEIAARESGVAIQDVLENL  111 (339)
Q Consensus        92 vl~~AA~esGl~~~dL~~~L  111 (339)
                      .|.+-|+++||+.+|+++.|
T Consensus         7 ~Li~eA~~~Gls~eeir~FL   26 (30)
T PF08671_consen    7 ELIKEAKESGLSKEEIREFL   26 (30)
T ss_dssp             HHHHHHHHTT--HHHHHHHH
T ss_pred             HHHHHHHHcCCCHHHHHHHH
Confidence            46677889999999987654


No 15 
>PF14437 MafB19-deam:  MafB19-like deaminase
Probab=29.93  E-value=78  Score=28.70  Aligned_cols=34  Identities=15%  Similarity=0.209  Sum_probs=26.2

Q ss_pred             CCccEEEEcCCCCCCCCCCHHHHHHHHHcCCCHHHh
Q psy1522         112 PSELAVWVDPGEVTGDPIDPVLEIAARESGVAIQDV  147 (339)
Q Consensus       112 P~EltlWVDPgeVSyR~~Dpvl~kAa~ESGL~~~dl  147 (339)
                      +.+++|||| ..|| ..+=..|..++.+.||+...+
T Consensus        99 g~~~tm~Vd-r~vC-~~C~~~i~~~a~~lGl~~L~I  132 (146)
T PF14437_consen   99 GRSMTMYVD-RDVC-GYCGGDIPSMAEKLGLKSLTI  132 (146)
T ss_pred             CCeEEEEEC-cccc-hHHHHHHHHHHHHcCCCeEEE
Confidence            999999999 6665 334488888888888876553


No 16 
>COG2442 Uncharacterized conserved protein [Function unknown]
Probab=29.69  E-value=96  Score=25.22  Aligned_cols=43  Identities=19%  Similarity=0.268  Sum_probs=34.7

Q ss_pred             CCCCCCCCCcceeEEecCCCCCHHHHHHHHHhCCCHHHHHhcCC
Q psy1522          69 WYPGKPLKGSAFRCLKTGDPIDPVLEIAARESGVAIQDVLENLP  112 (339)
Q Consensus        69 WyP~~P~kGsayRCIri~~~~Dpvl~~AA~esGl~~~dL~~~LP  112 (339)
                      |---.|.+..|-=||+ |.++.....--..++|++.+|+++.+|
T Consensus        12 ~I~~~P~i~gGkP~I~-GtRI~V~~Il~~l~~G~s~eeil~dyp   54 (79)
T COG2442          12 RIVITPGICGGKPCIR-GTRIPVWDILEMLAAGESIEEILADYP   54 (79)
T ss_pred             eeEeCCcccCCcceEe-CceecHHHHHHHHHCCCCHHHHHHhCC
Confidence            4456788888999999 777776666666669999999999888


No 17 
>PF14437 MafB19-deam:  MafB19-like deaminase
Probab=28.85  E-value=23  Score=32.02  Aligned_cols=27  Identities=19%  Similarity=0.271  Sum_probs=17.9

Q ss_pred             HHcC-CCHHHhhhcC-CCCceeeecCcccc
Q psy1522         138 RESG-VAIQDVLENL-PSELAVWVDPGEVR  165 (339)
Q Consensus       138 ~ESG-L~~~dl~l~L-P~ELTlWVDP~EVs  165 (339)
                      +|.+ +.-.+-...+ +++|||||| ..||
T Consensus        83 AE~~aiqqA~d~G~~~g~~~tm~Vd-r~vC  111 (146)
T PF14437_consen   83 AEAGAIQQAYDAGKTVGRSMTMYVD-RDVC  111 (146)
T ss_pred             HHHHHHHHHHHhcCccCCeEEEEEC-cccc
Confidence            5555 2222222334 899999999 9999


No 18 
>PF15508 NAAA-beta:  beta subunit of N-acylethanolamine-hydrolyzing acid amidase
Probab=28.27  E-value=3.1e+02  Score=22.21  Aligned_cols=39  Identities=21%  Similarity=0.213  Sum_probs=26.8

Q ss_pred             HHHHHHHHHHHHHHHhccCChhHHHHHHHHHHHHHHHHh
Q psy1522           3 HVEIQVALNFVISYLYNKLPRRRVNIFGEELEKALKEKF   41 (339)
Q Consensus         3 ~~EI~aAVnFl~~~L~~klprrrv~~F~e~L~~~L~erf   41 (339)
                      +.||++.++++..++..-+|...+-.+...+...|...|
T Consensus        26 k~~i~~l~~~~~~~~~~~~~~~~~~~~v~~~~~~l~~~~   64 (95)
T PF15508_consen   26 KDEIRELIEVLKDLLQSFVPSGKVLDFVDKLLPHLLRYL   64 (95)
T ss_pred             HHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHHHHHHhC
Confidence            568888888888887776777566666666665554443


No 19 
>PF06228 ChuX_HutX:  Haem utilisation ChuX/HutX;  InterPro: IPR010413 This entry consists of several hypothetical bacterial proteins of unknown function.; PDB: 2OVI_A 2PH0_B 3FM2_B 2HQV_A.
Probab=27.95  E-value=67  Score=28.63  Aligned_cols=26  Identities=31%  Similarity=0.538  Sum_probs=22.0

Q ss_pred             HHHHhCCCHHHHHhcCCCccEEEEcC
Q psy1522          96 AARESGVAIQDVLENLPSELAVWVDP  121 (339)
Q Consensus        96 AA~esGl~~~dL~~~LP~EltlWVDP  121 (339)
                      +|++.|++..|+.++||.++...++-
T Consensus         1 iA~~lgvse~ev~~~lp~~~~~~~~g   26 (141)
T PF06228_consen    1 IAKQLGVSELEVLAALPEEMVTFLPG   26 (141)
T ss_dssp             HHHHTTS-HHHHHHTSTTTTEEEEEG
T ss_pred             ChhHhCcCHHHHHHhCCHHHEEEccH
Confidence            58899999999999999999888874


No 20 
>cd03026 AhpF_NTD_C TRX-GRX-like family, Alkyl hydroperoxide reductase F subunit (AhpF) N-terminal domain (NTD) subfamily, C-terminal TRX-fold subdomain; AhpF is a homodimeric flavoenzyme which catalyzes the NADH-dependent reduction of the peroxiredoxin AhpC, which then reduces hydrogen peroxide and organic hydroperoxides. AhpF contains an NTD containing two contiguous TRX-fold subdomains similar to Pyrococcus furiosus protein disulfide oxidoreductase (PfPDO). It also contains a catalytic core similar to TRX reductase containing FAD and NADH binding domains with an active site disulfide. The proposed mechanism of action of AhpF is similar to a TRX/TRX reductase system. The flow of reducing equivalents goes from NADH - catalytic core of AhpF - NTD of AhpF - AhpC - peroxide substrates. The catalytic CXXC motif of the NTD of AhpF is contained in its C-terminal TRX subdomain.
Probab=22.29  E-value=64  Score=25.73  Aligned_cols=34  Identities=12%  Similarity=0.134  Sum_probs=28.6

Q ss_pred             CCccEEEEcCCCCCCCCCCHHHHHHHHHcC-CCHH
Q psy1522         112 PSELAVWVDPGEVTGDPIDPVLEIAARESG-VAIQ  145 (339)
Q Consensus       112 P~EltlWVDPgeVSyR~~Dpvl~kAa~ESG-L~~~  145 (339)
                      |-++.++++|+|-.|+.+.+.+++.+.+.+ +.+.
T Consensus        13 pv~i~~F~~~~C~~C~~~~~~~~~l~~~~~~i~~~   47 (89)
T cd03026          13 PINFETYVSLSCHNCPDVVQALNLMAVLNPNIEHE   47 (89)
T ss_pred             CEEEEEEECCCCCCcHHHHHHHHHHHHHCCCceEE
Confidence            889999999999999988898888887763 4443


No 21 
>cd01768 RA RA (Ras-associating) ubiquitin domain. The RA (Ras-associating) domain is structurally similar to ubiquitin and is present in one or two copies in a number of signalling molecules that bind and regulate a small GTPase called Ras or the Ras-related GTPases, Ral and Rap. RA-containing proteins include RalGDS, AF6, RIN1, RASSF1, SNX27, CYR1, STE50, and phospholipase C epsilon.
Probab=21.89  E-value=1e+02  Score=23.83  Aligned_cols=42  Identities=21%  Similarity=0.488  Sum_probs=30.6

Q ss_pred             CCCCCCCCcceeEEecC--CCCCHHHHHHHHHhCCCHHHHHhcCCCccEEE
Q psy1522          70 YPGKPLKGSAFRCLKTG--DPIDPVLEIAARESGVAIQDVLENLPSELAVW  118 (339)
Q Consensus        70 yP~~P~kGsayRCIri~--~~~Dpvl~~AA~esGl~~~dL~~~LP~EltlW  118 (339)
                      |.+.+ .|..|++|++.  .....+|..|++..|++-      -|.++.|+
T Consensus         5 ~~~~~-~~~~~kti~V~~~~t~~~Vi~~~l~k~~l~~------~~~~y~L~   48 (87)
T cd01768           5 YPEDP-SGGTYKTLRVSKDTTAQDVIQQLLKKFGLDD------DPEDYALV   48 (87)
T ss_pred             eCCcC-CCccEEEEEECCCCCHHHHHHHHHHHhCCcC------CcccEEEE
Confidence            34444 68899999984  567789999999999872      45555555


No 22 
>PF00788 RA:  Ras association (RalGDS/AF-6) domain;  InterPro: IPR000159 Proteins with this domain are mostly RasGTP effectors and include guanine-nucleotide releasing factor in mammals []. This factor stimulates the dissociation of GDP from the Ras-related RALA and RALB GTPases, which allows GTP binding and activation of the GTPases. It interacts and acts as an effector molecule for R-ras, K-Ras and Rap []. The domain is also present in a number of other proteins among them the sexual differentiation protein in yeast that is essential for mating and meiosis and yeast adenylate cyclase. These proteins contain repeated leucine-rich (LRR) segments.; GO: 0007165 signal transduction; PDB: 3EC8_A 2C5L_D 2BYF_A 2CS4_A 3KH0_A 2B3A_A 1RAX_A 2RGF_A 1WGR_A 1WXA_A ....
Probab=21.75  E-value=58  Score=24.78  Aligned_cols=49  Identities=20%  Similarity=0.330  Sum_probs=34.7

Q ss_pred             CCCCCcceeEEecC--CCCCHHHHHHHHHhCCCHHHHHhcCCCccEEE-EcCCCCCCC
Q psy1522          73 KPLKGSAFRCLKTG--DPIDPVLEIAARESGVAIQDVLENLPSELAVW-VDPGEVTGD  127 (339)
Q Consensus        73 ~P~kGsayRCIri~--~~~Dpvl~~AA~esGl~~~dL~~~LP~EltlW-VDPgeVSyR  127 (339)
                      ...-|..|++|.+.  .....+|..|++..||      ..=|.++.|| +......-|
T Consensus        11 ~~~~~~~~k~i~v~~~tTa~evi~~~l~k~~l------~~~~~~y~L~~~~~~~~~er   62 (93)
T PF00788_consen   11 DGSPGSTYKTIKVSSSTTAREVIEMALEKFGL------AEDPSDYCLVEVEESGGEER   62 (93)
T ss_dssp             TSSSCCSEEEEEEETTSBHHHHHHHHHHHTTT------SSSGGGEEEEEEECTTTEEE
T ss_pred             CCCCCccEEEEEECCCCCHHHHHHHHHHHhCC------CCCCCCEEEEEEEcCCCEEE
Confidence            33445579999984  5666999999999999      2457888888 555444444


No 23 
>COG0560 SerB Phosphoserine phosphatase [Amino acid transport and metabolism]
Probab=21.56  E-value=3.5e+02  Score=24.98  Aligned_cols=71  Identities=17%  Similarity=0.125  Sum_probs=41.5

Q ss_pred             CCcceeEEecCCCCCHHHHHHHHHhCCCHHHHHhcC-CC-ccEEEEcCCCCCCCCCCHHHHHHHHHcCCCHHH
Q psy1522          76 KGSAFRCLKTGDPIDPVLEIAARESGVAIQDVLENL-PS-ELAVWVDPGEVTGDPIDPVLEIAARESGVAIQD  146 (339)
Q Consensus        76 kGsayRCIri~~~~Dpvl~~AA~esGl~~~dL~~~L-P~-EltlWVDPgeVSyR~~Dpvl~kAa~ESGL~~~d  146 (339)
                      |-.+++|+.+.+..+-.+...|+..|++..---... -+ -+|=||.---+-...-+-.|.+.+++-|++..+
T Consensus        90 k~~G~~v~iiSgg~~~lv~~ia~~lg~d~~~an~l~~~dG~ltG~v~g~~~~~~~K~~~l~~~~~~~g~~~~~  162 (212)
T COG0560          90 KAAGAKVVIISGGFTFLVEPIAERLGIDYVVANELEIDDGKLTGRVVGPICDGEGKAKALRELAAELGIPLEE  162 (212)
T ss_pred             HHCCCEEEEEcCChHHHHHHHHHHhCCchheeeEEEEeCCEEeceeeeeecCcchHHHHHHHHHHHcCCCHHH
Confidence            334889999999999999999999999842110001 11 144444322222222334555666777776544


No 24 
>KOG3784|consensus
Probab=21.42  E-value=3.8e+02  Score=28.17  Aligned_cols=95  Identities=22%  Similarity=0.287  Sum_probs=57.8

Q ss_pred             cCChhHHHHHHHHHHHHHHHHhcCCCCCCCCCCCccchhHHHhhhcc------CCCCCCCCCCCcce--eEEecCCCCCH
Q psy1522          20 KLPRRRVNIFGEELEKALKEKFSGHWYPGKPLKDSSTNNKALKEKFS------GHWYPGKPLKGSAF--RCLKTGDPIDP   91 (339)
Q Consensus        20 klprrrv~~F~e~L~~~L~erf~~~w~~~~~~~~~~~le~~L~e~f~------~HWyP~~P~kGsay--RCIri~~~~Dp   91 (339)
                      +|++.+++-+...|++.|.+.-++     .=+.....+++.|.+.=.      .---    -.|+..  +|++ ++..|.
T Consensus        63 ~L~~~~~~~rr~~leqylqa~~q~-----~~l~~s~~~~~fL~~~q~~~~v~l~v~l----png~~i~i~~~~-s~tt~~  132 (407)
T KOG3784|consen   63 KLTPQQLDSRRRGLEQYLQAVCQD-----PVLARSELVQKFLMRAQPMEEVELDVFL----PNGEKITINCLV-SDTASL  132 (407)
T ss_pred             CCChhhhHHHHHHHHHHHHHHhcC-----ccccchhhhhHHHHhccccceeEEEEEc----cCCceEEEEEEe-cccHHH
Confidence            699999999999999999877666     112222333444433100      0000    134433  3443 788999


Q ss_pred             HHHHHHHHhCCCHHHHHhcCCCccEEEEcCCCCC
Q psy1522          92 VLEIAARESGVAIQDVLENLPSELAVWVDPGEVT  125 (339)
Q Consensus        92 vl~~AA~esGl~~~dL~~~LP~EltlWVDPgeVS  125 (339)
                      ++..||++.|+. +++...+---+..-.|||..+
T Consensus       133 vl~~v~~kl~l~-~e~i~~f~lFlvr~~~~~~ls  165 (407)
T KOG3784|consen  133 VLKSVCRKLGLP-DELIGYFGLFLVRDNDPGNLS  165 (407)
T ss_pred             HHHHHHhhcCCc-hHhhhheeeeEEeccCCCcce
Confidence            999999999998 666555544444444444433


No 25 
>COG3112 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=21.05  E-value=80  Score=27.90  Aligned_cols=38  Identities=21%  Similarity=0.184  Sum_probs=26.6

Q ss_pred             CCCHHHHHHHHHhCCCHHHHHhcCCCccEEEEcCCCCCCC
Q psy1522          88 PIDPVLEIAARESGVAIQDVLENLPSELAVWVDPGEVTGD  127 (339)
Q Consensus        88 ~~Dpvl~~AA~esGl~~~dL~~~LP~EltlWVDPgeVSyR  127 (339)
                      ++|. +++||...--+..++. +...|.|||+|-.||..|
T Consensus        38 kl~~-vl~~a~~~~~s~~~~~-~~G~Eytl~~~geEVmVr   75 (121)
T COG3112          38 KLDE-VLQAADTLKGSEREWQ-LAGHEYTLWMDGEEVMVR   75 (121)
T ss_pred             HHHH-HHHHHHHhhcChhhhe-ecCcEEEEEEcCceeeee
Confidence            4444 4455555544545652 558999999999999999


No 26 
>PF14941 OAF:  Transcriptional regulator, Out at first
Probab=20.10  E-value=43  Score=32.59  Aligned_cols=18  Identities=56%  Similarity=1.176  Sum_probs=14.7

Q ss_pred             CCCCC-------CCCCCcceeE-Eec
Q psy1522          68 HWYPG-------KPLKGSAFRC-LKT   85 (339)
Q Consensus        68 HWyP~-------~P~kGsayRC-Iri   85 (339)
                      -|||.       ++.|++.||| |+.
T Consensus       194 ~WYPCgLKYCkgkd~k~ssYrCGIKT  219 (240)
T PF14941_consen  194 EWYPCGLKYCKGKDQKPSSYRCGIKT  219 (240)
T ss_pred             eeEccchhhccCCCCCCCcccccccc
Confidence            69994       6679999999 775


Done!